# Aspirin Resistance Reversibility in Diabetic Patients

> **NCT01935193** · PHASE4 · UNKNOWN · sponsor: **Azienda Ospedaliera San Giovanni Battista** · enrollment: 160 (estimated)

## Conditions studied

- Aspirin Resistance

## Interventions

- **DRUG:** lysine acetylsalicylate

## Key facts

- **NCT ID:** NCT01935193
- **Lead sponsor:** Azienda Ospedaliera San Giovanni Battista
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-11
- **Primary completion:** 2013-08
- **Final completion:** —
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2013-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01935193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01935193, "Aspirin Resistance Reversibility in Diabetic Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01935193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*